Literature DB >> 33672931

Prognostic Value of Preoperative Echocardiographic Findings in Patients Undergoing Transvenous Lead Extraction.

Dorota Nowosielecka1, Wojciech Jacheć2, Anna Polewczyk3,4, Łukasz Tułecki5, Andrzej Kleinrok1,6, Andrzej Kutarski7.   

Abstract

(1) Background: In patients referred for transvenous lead extraction (TLE) transesophageal echocardiography (TEE) often reveals abnormalities related to chronically indwelling endocardial leads. The purpose of this study was to determine whether the results of pre-operative TEE might influence the long-term prognosis. (2)
Methods: We analyzed data from 936 TEE examinations performed at a high volume center in patients referred for TLE from 2015 to 2019. The follow-up was 566.2 ± 224.5 days. (3)
Results: Multivariate analysis of TEE parameters showed that vegetations (HR = 2.631 [1.738-3.983]; p < 0.001) and tricuspid valve (TV) dysfunction unrelated to the endocardial lead (HR = 1.481 [1.261-1.740]; p < 0.001) were associated with increased risk for long-term mortality. Presence of fibrous tissue binding sites between the lead and the superior vena cava (SVC) and/or right atrium (RA) wall (HR = 0.285; p = 0.035), presence of penetration or perforation of the lead through the cardiac wall up to the epicardium (HR = 0.496; p = 0.035) and presence of excessive lead loops (HR = 0.528; p = 0.026) showed a better prognosis. After adjustment the statistical model with recognized poor prognosis factors only vegetations were confirmed as a risk factor (HR = 2.613; p = 0.039). A better prognosis was observed in patients with fibrous tissue binding sites between the lead and the superior vena cava (SVC) and/or right atrium (RA) wall (HR = 0.270; p = 0.040). (4) Conclusions: Non-modifiable factors may have a negative influence on long-term survival after TLE. Various forms of connective tissue overgrowth and abnormal course of the leads modifiable by TLE can be a factor of better prognosis after TLE.

Entities:  

Keywords:  long-term survival; transesophageal echocardiography; transvenous lead extraction; tricuspid valve dysfunction; vegetations

Mesh:

Substances:

Year:  2021        PMID: 33672931      PMCID: PMC7918219          DOI: 10.3390/ijerph18041862

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  35 in total

1.  Outcomes and Complications of Lead Removal: Can We Establish a Risk Stratification Schema for a Collaborative and Effective Approach?

Authors:  Hai-Xia Fu; Xin-Miao Huang; L I Zhong; Michael J Osborn; Samuel J Asirvatham; Raul E Espinosa; Peter A Brady; Hon-Chi Lee; Kevin L Greason; Larry M Baddour; Rizwan M Sohail; Nancy G Acker; David O Hodge; Paul A Friedman; Yong-Mei Cha
Journal:  Pacing Clin Electrophysiol       Date:  2015-09-22       Impact factor: 1.976

2.  Cardiac implanted electronic device-related infective endocarditis: clinical features, management, and outcomes of 80 consecutive patients.

Authors:  David H Kim; Jesalyn Tate; William F Dresen; Frank C Papa; Karen C Bloch; Spyros A Kalams; Christopher R Ellis; Michael T Baker; Daniel J Lenihan; Lisa A Mendes
Journal:  Pacing Clin Electrophysiol       Date:  2014-07-25       Impact factor: 1.976

3.  Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection.

Authors:  Pier Giorgio Golzio; Daniele Errigo; Mattia Peyracchia; Elisa Gallo; Simone Frea; Davide Castagno; Carlo Budano; Carla Giustetto; Mauro Rinaldi
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2019-06       Impact factor: 2.160

4.  Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study.

Authors:  Igor Diemberger; Rachele Bonfiglioli; Cristian Martignani; Maddalena Graziosi; Mauro Biffi; Stefano Lorenzetti; Matteo Ziacchi; Cristina Nanni; Stefano Fanti; Giuseppe Boriani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-08       Impact factor: 9.236

5.  Impact of ICD lead on the system durability, predictors of long-term survival following ICD system extraction.

Authors:  Wojciech Jacheć; Andrzej Tomasik; Anna Polewczyk; Andrzej Kutarski
Journal:  Pacing Clin Electrophysiol       Date:  2017-09-27       Impact factor: 1.976

6.  Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms.

Authors:  Ronald Lo; Michael D'Anca; Todd Cohen; Todd Kerwin
Journal:  J Invasive Cardiol       Date:  2006-12       Impact factor: 2.022

7.  Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.

Authors:  Jean-Claude Deharo; Amandine Quatre; Julien Mancini; Paul Khairy; Yvan Le Dolley; Jean-Paul Casalta; Eric Peyrouse; Sébastien Prévôt; Franck Thuny; Frédéric Collart; Didier Raoult; Gilbert Habib; Frédéric Franceschi
Journal:  Heart       Date:  2012-05       Impact factor: 5.994

8.  Lead Extraction for Treatment of Cardiac Device Infection: A 20-Year Single Centre Experience.

Authors:  Sean Gomes; Gregory Cranney; Michael Bennett; Robert Giles
Journal:  Heart Lung Circ       Date:  2016-08-12       Impact factor: 2.975

9.  Long-Term Outcomes Following Transvenous Lead Extraction.

Authors:  Sean Gomes; Gregory Cranney; Michael Bennett; Robert Giles
Journal:  Pacing Clin Electrophysiol       Date:  2016-02-18       Impact factor: 1.976

10.  Transesophageal Echocardiography As a Monitoring Tool During Transvenous Lead Extraction-Does It Improve Procedure Effectiveness?

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Łukasz Tułecki; Konrad Tomków; Paweł Stefańczyk; Andrzej Tomaszewski; Wojciech Brzozowski; Dorota Szcześniak-Stańczyk; Andrzej Kleinrok; Andrzej Kutarski
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

View more
  1 in total

1.  "Ghost", a Well-Known but Not Fully Explained Echocardiographic Finding during Transvenous Lead Extraction: Clinical Significance.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Łukasz Tułecki; Paweł Stefańczyk; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2022-10-01       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.